Lukas von Stülpnagel

8PUBLICATIONS
112CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Artificial life and complex adaptive systemsRespiratory diseasesGene expression (incl. microarray and other genome-wide approaches)Epidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 29, 2026
Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

|Sep 23, 2025
Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial.

Luisa Freyer, Peter Spielbichler, Lukas von Stülpnagel

|Jul 24, 2025
Cardiac autonomic function score: a novel risk stratification tool in the cardiac intensive care unit based on periodic repolarization dynamics and deceleration capacity of heart rate (LMU-eICU study).

Mathias Klemm, Lukas von Stülpnagel, Valentin Ostermaier

|Jul 31, 2024
Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure.

Andreas A Boehmer, Tim Schubert, Moritz Rothe

|Mar 08, 2023
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies.

Julia Hoffmann, Sabine Hanß, Monika Kraus

|Aug 28, 2022
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial.

Konstantinos D Rizas, Luisa Freyer, Nikolay Sappler

Pageof 2

Frequent Collaborators

6 joint publications

Steffen Massberg

5 joint publications

Axel Bauer

5 joint publications

Konstantinos D Rizas

4 joint publications

Elodie Eiffener